Lineage Cell Therapeutics (LCTX) Shares Outstanding (Diluted) (2014 - 2026)
Lineage Cell Therapeutics (LCTX) Shares Outstanding (Diluted) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 52.24 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 256.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 680.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 66.36 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 198.10 Mn |
| 10 | Lineage Cell Therapeutics | 251.15 Mn | 188.44 Mn | 1.73 Mn | 261.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 261.18 Mn |
| Dec 31, 2025 | 230.12 Mn |
| Sep 30, 2025 | 228.85 Mn |
| Jun 30, 2025 | 228.36 Mn |
| Mar 31, 2025 | 226.05 Mn |
| Dec 31, 2024 | 200.19 Mn |
| Sep 30, 2024 | 188.84 Mn |
| Jun 30, 2024 | 188.81 Mn |
| Mar 31, 2024 | 182.91 Mn |
| Dec 31, 2023 | 172.66 Mn |
| Sep 30, 2023 | 174.87 Mn |
| Jun 30, 2023 | 170.59 Mn |
| Mar 31, 2023 | 170.13 Mn |
| Dec 31, 2022 | 169.79 Mn |
| Sep 30, 2022 | 169.79 Mn |
| Jun 30, 2022 | 169.73 Mn |
| Mar 31, 2022 | 169,647.00 |
| Dec 31, 2021 | 167.62 Mn |
| Sep 30, 2021 | 167.62 Mn |
| Jun 30, 2021 | 162,914.00 |